CompoAtlas

Astazine

Natural health product licensed in Canada

Licence holder
Alliance Principle Ingredients / Neutrical Solutions Inc.
NPN or DIN-HM
80087966
Status
Active licence
Licence date
22 August 2018
Revision date
Not provided
Form
Capsule, molle
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
3,3'-Dihydroxy-bêta, bêta-carotène-4,4'-diène

Source : Haematococcus pluvialis - whole

12 mgNot calculated

Non-medicinal ingredients

Glycérine, Gélatine, Vitamine E, Huile de carthame, Eau purifiée

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 yearsminimum: 1 Capsule ; maximum: 2 Capsule1 Tous les jours

Uses authorised in Canada

Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps reduce eye strain and eye fatigue. Helps reduce C-reactive protein levels, a clinical marker of inflammation. Helps to improve physical endurance. Helps reduce 8-hydroxy-2'-deoxyguanosine, a marker of DNA oxidative damage. Helps support eye health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80087966

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line